Evidence map›Paper›PMID 36824760›Full record

ArticlebioRxiv : the preprint server for biology2023

Dephosphorylation of 4EBP1/2 Induces Prenatal Neural Stem Cell Quiescence.

Laura C Geben, Asa A Brockman, Mary Bronwen L Chalkley, Serena R Sweet, Julia E Gallagher, Alexandra L Scheuing, Richard B Simerly, Kevin C Ess, Jonathan M Irish, Rebecca A Ihrie

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Laura C GebenProgram in Pharmacology, Vanderbilt University, Nashville, TN, 37235, USA.
Asa A BrockmanDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Mary Bronwen L ChalkleyDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Serena R SweetDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Julia E GallagherDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Alexandra L ScheuingDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Richard B SimerlyDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Kevin C EssDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Jonathan M IrishDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Rebecca A IhrieDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37235, USA.
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Single-Cell Biology and Data Analysis Shared Resource (SCB-DA SR)U54CA217450 · NCI · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2018 to 2022
$8.5M
Single Cell Methods for Bioeffector Discovery and AnalysisR01CA226833 · NCI · VANDERBILT UNIVERSITY · PI BRIAN O BACHMANN, Jonathan Michael Irish · 2019 to 2026
$6.1M
Training Program in Stem Cell and Regenerative Developmental BiologyT32HD007502 · NICHD · VANDERBILT UNIVERSITY · PI WRIGHT, CHRISTOPHER V · 1997 to 2022
$5.4M
Leptin and Developmental Programming of Hypothalamic Autonomic OutflowR01DK106476 · NIDDK · VANDERBILT UNIVERSITY · PI SIMERLY, RICHARD B · 2016 to 2024
$3.7M
Identifying mTOR Dependent Periods During Brain DevelopmentR01NS118580 · NINDS · VANDERBILT UNIVERSITY · PI ESS, KEVIN C, IHRIE, REBECCA A · 2020 to 2024
$2.1M
Quantifying Differences in mTOR Activity and Tumor Development Between Neural Stem Cell MicrodomainsR01NS096238 · NINDS · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A · 2016 to 2020
$1.7M
NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA226833NCI NIH HHS U54 CA217450NEI NIH HHS P30 EY008126NICHD NIH HHS F31 HD106890NICHD NIH HHS T32 HD007502NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK106476NIDDK NIH HHS U24 DK059637NIGMS NIH HHS T32 GM007628NINDS NIH HHS F31 NS120608NINDS NIH HHS R01 NS096238NINDS NIH HHS R01 NS118580
6 · The paper itself

Abstract

A limiting factor in the regenerative capacity of the adult brain is the abundance and proliferative ability of neural stem cells (NSCs). Adult NSCs are derived from a subpopulation of embryonic NSCs that temporarily enter quiescence during mid-gestation and remain quiescent until postnatal reactivation. Here we present evidence that the mechanistic/mammalian target of rapamycin (mTOR) pathway regulates quiescence entry in embryonic NSCs of the developing forebrain. Throughout embryogenesis, two downstream effectors of mTOR, p-4EBP1/2 T37/46 and p-S6 S240/244, were mutually exclusive in NSCs, rarely occurring in the same cell. While 4EBP1/2 was phosphorylated in stem cells undergoing mitosis at the ventricular surface, S6 was phosphorylated in more differentiated cells migrating away from the ventricle. Phosphorylation of 4EBP1/2, but not S6, was responsive to quiescence induction in cultured embryonic NSCs. Further, inhibition of p-4EBP1/2, but not p-S6, was sufficient to induce quiescence. Collectively, this work offers new insight into the regulation of quiescence entry in embryonic NSCs and, thereby, correct patterning of the adult brain. These data suggest unique biological functions of specific posttranslational modifications and indicate that the preferential inhibition of such modifications may be a useful therapeutic approach in neurodevelopmental diseases where NSC numbers, proliferation, and differentiation are altered.

Identifiers

PMID36824760
PMCPMC9948964
OpenAlexW4320896697

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.